Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls
ClinicalTrials.gov · NCT06789705 · Registry updated: 2025-02-19
- Condition / research focus
- Central Diabetes Insipidus
- Sponsor
- University Hospital, Basel, Switzerland
- Countries with listed sites
- Switzerland
- Registry dates and results
- Start: 2025-01-27. Completion: 2026-12 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- MDMA (drug)
- Placebo (other)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- University Hospital Basel
Basel, Switzerland
Site recruitment: Recruiting